What is a prescription-only dermatology cream platform in India?

A regulated B2C/B2B digital or physical distribution network that sells dermatological creams only upon valid medical prescription. Customers consult licensed dermatologists (via telemedicine or clinic), receive prescription, then order verified products. This model prevents OTC misuse that has created drug-resistant Trichophyton indotineae infections across India (March 2026 reports).

How much does it cost to start this business in India?

₹25–45 lakh for MVP launch: Tech platform (₹8–12L), regulatory licenses & compliance (₹5–8L), initial pharma inventory (₹8–15L), marketing (₹4–10L). Full-scale operation with 50+ clinic partners costs ₹1–2 crore.

Is this business profitable in India?

Yes. With 50 clinic partners averaging 500 monthly prescriptions at ₹250 margin per unit = ₹62.5 lakh/month (₹750L annually). Add telemedicine fees (₹60–100L) and clinic subscriptions (₹30–180L). Net margins 30–40% after compliance costs. Payback period: 12–18 months.

What regulations apply to this business in India?

Drugs and Cosmetics Act 1940 (Section 21, Form 20B for retail licence); Pharmacy Council registration; Schedule H regulations for corticosteroids (prescription mandatory); NPPA price caps on controlled drugs; GST 5% on pharmaceutical products; state Drug Controller approval; telemedicine RMP guidelines under Indian Medical Council Act 1956.

Prescription Dermatology Cream Platform India 2026 – Startup

AI SummaryA prescription-only dermatology cream distribution platform addresses India's emerging ₹800-crore OTC cream misuse crisis, which has spawned drug-resistant fungal infections (Trichophyton indotineae, identified March 2026). The hybrid B2C/B2B model targets dermatology clinics, hospitals, and direct consumers, with projected annual revenue of ₹90–560 lakh from product margins, telemedicine fees, and clinic subscriptions. The timing is critical in 2026 as regulatory bodies (NPPA, state Drug Controllers) are tightening OTC steroid sales; early movers capturing clinic partnerships will dominate. Ideal for healthcare entrepreneurs, MBAs in pharma/healthtech, and pharmacists with regulatory expertise.